| An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B (NCT00467545) | Novartis Pharmaceuticals | 2007-04-01 |
| A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection (NCT00393484) | Bristol-Myers Squibb | 2007-02-01 |
| Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection (NCT00388674) | Bristol-Myers Squibb | 2006-12-18 |
| Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B (NCT00412529) | Novartis Pharmaceuticals | 2006-12-01 |
| Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients (NCT00441974) | GlaxoSmithKline | 2006-12-01 |
| Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 (NCT00403585) | GlaxoSmithKline | 2006-07-01 |
| Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. (NCT00298363) | Gilead Sciences | 2006-04-01 |
| Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil (NCT00307489) | Gilead Sciences | 2006-03-01 |
| Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B (NCT00324961) | GlaxoSmithKline | 2006-01-01 |
| Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection (NCT00277576) | PowderMed | 2006-01-01 |
| Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients (NCT00316719) | GlaxoSmithKline | 2006-01-01 |
| Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B (NCT00291616) | Seoul National University Hospital | 2005-12-01 |
| Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases. (NCT00263614) | Gilead Sciences | 2005-12-01 |
| Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers (NCT01412567) | Govind Ballabh Pant Hospital | 2005-10-01 |
| Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta (NCT00117533) | National Taiwan University Hospital | 2005-09-01 |
| 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV (NCT00225537) | MTmedical Institute of Health | 2005-09-01 |
| Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B (NCT00307242) | Thomas Jefferson University | 2005-06-17 |
| A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B (NCT00116805) | Gilead Sciences | 2005-06-01 |
| Long Term Follow-up of Pegylated-Interferon Alpha-2b (NCT00146705) | Foundation for Liver Research | 2005-05-01 |
| Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis (NCT00347009) | GlaxoSmithKline | 2005-05-01 |
| Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies (NCT00142298) | Novartis Pharmaceuticals | 2005-03-01 |
| Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B (NCT00132652) | Novartis | 2005-02-01 |
| A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B (NCT00117676) | Gilead Sciences | 2005-02-01 |
| Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment (NCT00226382) | Chinese University of Hong Kong | 2005-01-01 |
| Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin (NCT00635310) | National Taiwan University Hospital | 2005-01-01 |
| Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a (NCT00199732) | University Hospital, Limoges | 2004-12-01 |
| Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B (NCT00115245) | Novartis | 2004-11-01 |
| The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) (NCT00397540) | Seoul National University Hospital | 2004-10-01 |
| Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients (NCT00221286) | University Hospital, Bonn | 2004-09-01 |
| Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B (NCT00131742) | Novartis | 2004-07-01 |
| Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B (NCT00095121) | Gilead Sciences | 2004-06-01 |
| Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B (NCT00895596) | LG Life Sciences | 2004-03-01 |
| An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection (NCT01037062) | Bristol-Myers Squibb | 2003-12-01 |
| A Phase II Dose Response Study in Japan in Chronic Hepatitis B (NCT01022801) | Bristol-Myers Squibb | 2003-08-01 |
| Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B (NCT00071201) | Gilead Sciences | 2003-06-01 |
| A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection (NCT01020565) | Bristol-Myers Squibb | 2003-02-01 |
| A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B (NCT00057265) | Novartis | 2003-02-01 |
| A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B (NCT00857675) | GlaxoSmithKline | 2002-12-01 |
| Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy (NCT01037166) | Bristol-Myers Squibb | 2002-12-01 |
| Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients (NCT00226447) | Chinese University of Hong Kong | 2002-12-01 |
| Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B (NCT00040144) | Alexion Pharmaceuticals, Inc. | 2002-07-01 |
| A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone (NCT00354653) | ViiV Healthcare | 2002-02-09 |
| A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine (NCT00036608) | Bristol-Myers Squibb | 2002-01-01 |
| Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B (NCT00048945) | Hoffmann-La Roche | 2002-01-01 |
| Steatohepatitis in Chronic Hepatitis B (NCT05317260) | Mahidol University | 2002-01-01 |
| A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen (NCT00035633) | Bristol-Myers Squibb | 2001-12-01 |
| A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen (NCT00035789) | Bristol-Myers Squibb | 2001-11-01 |
| Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection (NCT00023153) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-08-01 |
| Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B (NCT00988767) | Institut National de la Santé Et de la Recherche Médicale, France | 2001-02-01 |
| Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia) (NCT00338780) | Chinese University of Hong Kong | 2000-11-01 |
| Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) (NCT00140725) | GlaxoSmithKline | 2000-04-01 |
| Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B (NCT00275938) | National Taiwan University Hospital | 1998-10-01 |
| Lamivudine for Chronic Hepatitis B (NCT00001457) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1995-09-01 |
| Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects (NCT02202473) | Southeast University, China | |
| Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test (NCT01204827) | Hadassah Medical Organization | |
| Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B (NCT01198860) | Nguyen Thi Trieu, MD | |
| Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy (NCT00409019) | Novartis Pharmaceuticals | |
| An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options (NCT00042393) | Gilead Sciences | |
| Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection. (NCT00037622) | Alexion Pharmaceuticals, Inc. | |